RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yashoda V. Pramar to Spironolactone

This is a "connection" page, showing publications Yashoda V. Pramar has written about Spironolactone.
Connection Strength

0.809
  1. Graves R, Phan KV, Bostanian LA, Mandal TK, Pramar YV. Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt. Int J Pharm Compd. 2017 Jul-Aug; 21(4):334-338.
    View in: PubMed
    Score: 0.576
  2. Pramar YV. Microbiological Stability of Allopurinol, Clindamycin Hydrochloride, Naltrexone Hydrochloride, Spironolactone and Ursodiol Oral Liquids Compounded in PCCA Base, SuspendIt?. Int J Pharm Compd. 2024 Jul-Aug; 28(4):316-320.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support